Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Inv. presentation
|
|
Outlook Therapeutics, Inc. (ONS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/29/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/07/2022 |
SC 13D/A
| Tenshi Healthcare Pte. Ltd. reports a 10.2% stake in Outlook Therapeutics, Inc. |
| 04/22/2022 |
SC 13D/A
| Tenshi Healthcare Pte. Ltd. reports a 25.6% stake in Outlook Therapeutics, Inc. |
| 02/01/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/01/2021 |
SC 13D/A
| BioLexis Pte Ltd. reports a 35.5% stake in Outlook Therapeutics, Inc. |
| 02/04/2021 |
SC 13D/A
| Syntone Ventures LLC reports a 11.7% stake in Outlook Therapeutics, Inc. |
| 02/02/2021 |
SC 13D/A
| BioLexis Pte Ltd. reports a 38.6% stake in Outlook Therapeutics, Inc. |
| 03/24/2020 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 65.3% stake in Outlook Therapeutics, Inc. |
| 02/27/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/31/2020 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 51.6% stake in Outlook Therapeutics, Inc. |
| 12/30/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 51.7% stake in Outlook Therapeutics, Inc. |
| 06/19/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 62.4% stake in Outlook Therapeutics, Inc. |
| 04/16/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 70.9% stake in Outlook Therapeutics, Inc. |
| 02/05/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/03/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 79.5% stake in Outlook Therapeutics, Inc. |
| 11/09/2018 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 78.1% stake in Oncobiologics, Inc. |
| 07/20/2018 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 77.7% stake in Oncobiologics, Inc. |
| 06/25/2018 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 77.5% stake in Oncobiologics, Inc. |
| 11/01/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|